DANIEL HAKEEM: Open Payments
NPI 1346609179 · BERLIN, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$385 in 13 payments from 7 companies in 2025. Trend: 2023 $319 · 2024 $251 · 2025 $385
Food & beverage: $385
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 1 | $138 |
| Novo Nordisk Inc | 4 | $81 |
| Lilly USA, LLC | 3 | $53 |
| Smith+Nephew, Inc. | 2 | $51 |
| Merck Sharp & Dohme LLC | 1 | $27 |
| Tactile Systems Technology Inc | 1 | $19 |
| Olympus America Inc. | 1 | $16 |
Products named: Axios, Wegovy, MOUNJARO, ALLEVYN LIFE L 15.4X15.4 CTN10, KEYTRUDA, PICO 7, Flexitouch Plus, ZEPBOUND.
Industry payments across MD — which companies pay providers there.
